Hyperlipidaemia and Primary Prevention of Coronary Heart Disease: Are the Right Patients Being Treated?

Abstract

The Standing Medical Advisory Committee recommendations on the management of hyperlipidaemia in primary prevention of coronary heart disease are not widely used. Large savings could be made by correctly identifying and treating individuals at high risk. We recommend use of the full Framingham risk score in assessment of coronary heart disease risk in primary care.